WallStreetZenWallStreetZen

NASDAQ: CDMO
Avid Bioservices Inc Earnings & Revenue

CDMO past revenue growth

How has CDMO's revenue growth performed historically?
Company
-6.27%
Industry
89.08%
Market
19.74%
CDMO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CDMO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CDMO's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CDMO earnings and revenue history

Current Revenue
$139.9M
Current Earnings
-$140.8M
Current Profit Margin
-100.6%

CDMO Return on Equity

Current Company
-91.6%
Current Industry
16.8%
Current Market
28.2%
CDMO's Return on Equity (-91.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CDMO announces earnings.

CDMO Return on Assets

Current Company
-33.3%
Current Industry
3.2%
CDMO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CDMO Return on Capital Employed

Current Company
-8.49%
Current Industry
-42.4%
CDMO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CDMO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CDMO$139.91M-$11.48M-$140.75M+21.15%N/A
VALN$164.47MN/A-$26.23M-33.94%N/A
OABI$21.05M-$59.23M-$63.48M-24.34%N/A
THRD$0.00-$28.88M-$29.60MN/AN/A
ALEC$96.41M-$107.26M-$120.61M+27.72%N/A

CDMO earnings dates

Next earnings date
Sep 5, 2024

Avid Bioservices Earnings & Revenue FAQ

What were CDMO's earnings last quarter?

On Invalid Date, Avid Bioservices (NASDAQ: CDMO) reported Q1 2024 earnings per share (EPS) of -$1.95, up 19,400% year over year. Total Avid Bioservices earnings for the quarter were -$123.10 million. In the same quarter last year, Avid Bioservices's earnings per share (EPS) was -$0.01.

If you're new to stock investing, here's how to buy Avid Bioservices stock.

What was CDMO's earnings growth in the past year?

As of Q3 2024, Avid Bioservices's earnings has grown year over year. Avid Bioservices's earnings in the past year totalled -$140.75 million.

What is CDMO's earnings date?

Avid Bioservices's earnings date is Invalid Date. Add CDMO to your watchlist to be reminded of CDMO's next earnings announcement.

What was CDMO's revenue last quarter?

On Invalid Date, Avid Bioservices (NASDAQ: CDMO) reported Q1 2024 revenue of $42.98 million up 7.98% year over year. In the same quarter last year, Avid Bioservices's revenue was $39.80 million.

What was CDMO's revenue growth in the past year?

As of Q3 2024, Avid Bioservices's revenue has grown -6.27% year over year. This is 95.34 percentage points lower than the US Biotechnology industry revenue growth rate of 89.08%. Avid Bioservices's revenue in the past year totalled $139.91 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.